Home NDC 24338-155 DANZITEN
Product NDC 24338-155
11-digit product format 243380155
Labeler code 24338
Product ID 24338-155_62029a35-74af-47bc-9b7b-93dcaddfd278
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name nilotinib
Dosage form TABLET
Route ORAL
Labeler Azurity Pharmaceuticals, Inc.
Application NDA219293
Marketing category NDA
Marketing start 2024-11-30
Substance NILOTINIB
Active strength 95 mg/1
Pharmacologic classes Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219293-001 DANZITEN NILOTINIB TARTRATE EQ 71MG BASE TABLET / ORAL RLD, RS 2024-11-07 N219293-002 DANZITEN NILOTINIB TARTRATE EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219293-001 10874671 2040-02-18 Drug product 2024-11-08 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 N219293-001 12403140 2040-02-18 Drug product 2025-09-22 N219293-001 12629369 2040-02-18 Drug product 2026-06-05 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 N219293-002 12403140 2040-02-18 Drug product 2025-09-22 N219293-002 12629369 2040-02-18 Drug product 2026-06-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD, RS 2024-11-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD, RS 2024-11-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD 2024-11-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD 2024-11-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD 2024-11-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD 2024-11-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD 2024-11-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 2680178bc6a6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-001 DANZITEN EQ 71MG BASE TABLET / ORAL RLD, RS 2024-11-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-002 DANZITEN EQ 95MG BASE TABLET / ORAL RLD, RS 2024-11-07 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-001 12403140 2040-02-18 Drug product 2025-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219293-002 12403140 2040-02-18 Drug product 2025-09-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-001 12403140 2040-02-18 Drug product 2025-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219293-002 12403140 2040-02-18 Drug product 2025-09-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 2680178bc6a6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-001 10874671 2040-02-18 Drug product 2024-11-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-001 11793809 2040-02-18 Drug product 2024-11-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-001 12403140 2040-02-18 Drug product 2025-09-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-001 12629369 2040-02-18 Drug product 2026-06-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-002 10874671 2040-02-18 Drug product 2024-11-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-002 11793809 2040-02-18 Drug product 2024-11-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-002 12403140 2040-02-18 Drug product 2025-09-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219293-002 12629369 2040-02-18 Drug product 2026-06-05 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base DANZITEN
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NILOTINIB 95 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination F41401512X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2698564 Internal RxNorm lookup 2698570 Internal RxNorm lookup 2698572 Internal RxNorm lookup 2698574 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 24338-155-01 DANZITEN 4 in 1 CARTON TABLET 4 3 24338-155-02 DANZITEN 2 in 1 CARTON TABLET 2 3 24338-155-03 DANZITEN 14 in 1 BLISTER PACK TABLET 14 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 24338-155 DANZITEN (NILOTINIB) TABLET [AZURITY PHARMACEUTICALS, INC.] 2 Current NDC, 3 package rows 20241130_d288d165-3505-49bb-9b2e-124490d65f49.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join DANZITEN NILOTINIB Azurity Pharmaceuticals, Inc. d288d165-3505-49bb-9b2e-124490d65f49 2025-07-28 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 219293 application number: NDA219293 ndc (product): 24338-155
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 24338-155-01 24338015501 4 CARTON in 1 CARTON (24338-155-01) / 2 BLISTER PACK in 1 CARTON (24338-155-02) / 14 TABLET in 1 BLISTER PACK (24338-155-03) 4 carton 2024-11-30 No No Current 24338-155-02 24338015502 2 in 1 CARTON Historical 24338-155-03 24338015503 14 in 1 BLISTER PACK Historical